These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34678197)

  • 21. Political Economy of Non-Communicable Disease (NCD) prevention and control in Lebanon: identifying challenges and opportunities for policy change and care provision reforms.
    Bou-Orm IR; Loffreda G; Diaconu K; Witter S; deVos P
    BMC Public Health; 2023 Dec; 23(1):2526. PubMed ID: 38110967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assuring Bangladesh's future: non-communicable disease risk factors among the adolescents and the existing policy responses.
    Biswas T; Azzopardi P; Anwar SN; de Vries TD; Encarnacion-Cruz LM; Hasan MM; Huda MM; Pervin S; Das Gupta R; Mitra DK; Rawal LB; Al Mamun A
    J Health Popul Nutr; 2022 May; 41(1):22. PubMed ID: 35578321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noncommunicable Diseases Prevention In Low- and Middle-Income Countries: An Overview of Health in All Policies (HiAP).
    Ndubuisi NE
    Inquiry; 2021; 58():46958020927885. PubMed ID: 34420412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Policy Instruments for Health Promotion: A Comparison of WHO Policy Guidance for Tobacco, Alcohol, Nutrition and Physical Activity.
    Gelius P; Messing S; Tcymbal A; Whiting S; Breda J; Abu-Omar K
    Int J Health Policy Manag; 2022 Sep; 11(9):1863-1873. PubMed ID: 34634879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tackling the non-communicable disease epidemic: a framework for policy action in low- and middle-income countries.
    Owusu MF; Adu J; Gyamfi S; Martin-Yeboah E; Dortey BA
    Pan Afr Med J; 2024; 47():82. PubMed ID: 38737222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Big" Food, Tobacco, and Alcohol: Reducing Industry Influence on Noncommunicable Disease Prevention Laws and Policies Comment on "Addressing NCDs: Challenges From Industry Market Promotion and Interferences".
    Reeve B; Gostin LO
    Int J Health Policy Manag; 2019 Jul; 8(7):450-454. PubMed ID: 31441282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From Local Action to Global Policy: A Comparative Policy Content Analysis of National Policies to Address Musculoskeletal Health to Inform Global Policy Development.
    Schneider CH; Parambath S; Young JJ; Jain S; Slater H; Sharma S; Kopansky-Giles D; March L; Briggs AM
    Int J Health Policy Manag; 2023; 12():7031. PubMed ID: 37579444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys.
    Holloway KA; Henry D
    PLoS Med; 2014 Sep; 11(9):e1001724. PubMed ID: 25226527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-communicable disease prevention in Mexico: policies, programs and regulations.
    Aceves B; Ingram M; Nieto C; de Zapien JG; Rosales C
    Health Promot Int; 2020 Apr; 35(2):409-421. PubMed ID: 31006024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Policy implementation and recommended actions to create healthy food environments using the Healthy Food Environment Policy Index (Food-EPI): a comparative analysis in South Asia.
    Pineda E; Atanasova P; Wellappuli NT; Kusuma D; Herath H; Segal AB; Vandevijvere S; Anjana RM; Shamim AA; Afzal S; Akter F; Aziz F; Gupta A; Hanif AA; Hasan M; Jayatissa R; Jha S; Jha V; Katulanda P; Khawaja KI; Kumarendran B; Loomba M; Mahmood S; Mridha MK; Pradeepa R; Aarthi GR; Tyagi A; Kasturiratne A; Sassi F; Miraldo M
    Lancet Reg Health Southeast Asia; 2024 Jul; 26():100428. PubMed ID: 39040122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systems Thinking as a Framework for Analyzing Commercial Determinants of Health.
    Knai C; Petticrew M; Mays N; Capewell S; Cassidy R; Cummins S; Eastmure E; Fafard P; Hawkins B; Jensen JD; Katikireddi SV; Mwatsama M; Orford J; Weishaar H
    Milbank Q; 2018 Sep; 96(3):472-498. PubMed ID: 30277610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Big Tobacco, Alcohol, and Food and NCDs in LMICs: An Inconvenient Truth and Call to Action Comment on "Addressing NCDs: Challenges From Industry Market Promotion and Interferences".
    Delobelle P
    Int J Health Policy Manag; 2019 Dec; 8(12):727-731. PubMed ID: 31779301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of School Nutrition Policies to Address Noncommunicable Diseases in Uzbekistan and Kyrgyzstan.
    Alonge O; Homsi M; Rizvi MS; Malykh R; Geffert K; Kasymova N; Tilenbaeva N; Isakova L; Kushubakova M; Mavlyanova D; Mamyrbaeva T; Duishenkulova M; Pinedo A; Andreeva O; Wickramasinghe K
    Glob Health Sci Pract; 2024 Aug; 12(4):. PubMed ID: 38986582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of UN high-level meetings on non-communicable disease funding and policy implementation.
    Akselrod S; Collins TE; Berlina D; Collins A; Allen LN
    BMJ Glob Health; 2023 Oct; 8(10):. PubMed ID: 37907235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global lung cancer mortality trends and lifestyle modifications: preliminary analysis.
    Khaltaev N; Axelrod S
    Chin Med J (Engl); 2020 Jul; 133(13):1526-1532. PubMed ID: 32568874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Powerful Allies and Weak Consensus: Towards a Deeper Understanding of how Health-Harming Industries Seek to Influence Global Health Governance Comment on "Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases".
    Zenone M; Hawkins B
    Int J Health Policy Manag; 2022 Jul; 11(7):1222-1224. PubMed ID: 34814667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advancing public health policy making through research on the political strategies of alcohol industry actors.
    McCambridge J; Kypri K; Sheldon TA; Madden M; Babor TF
    J Public Health (Oxf); 2020 May; 42(2):262-269. PubMed ID: 31220307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The politics of non-communicable diseases in the global South.
    Reubi D; Herrick C; Brown T
    Health Place; 2016 May; 39():179-87. PubMed ID: 26365886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using System Dynamics to Understand Transnational Corporate Power in Diet-Related Non-communicable Disease Prevention Policy-Making: A Case Study of South Africa.
    Milsom P; Tomoaia-Cotisel A; Smith R; Modisenyane SM; Walls H
    Int J Health Policy Manag; 2023; 12():7641. PubMed ID: 38618803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementing a national non-communicable disease policy in sub-Saharan Africa: Experiences of key stakeholders in Ghana.
    Nyaaba GN; Stronks K; Masana L; Larrea-Killinger C; Agyemang C
    Health Policy Open; 2020 Dec; 1():100009. PubMed ID: 37383312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.